Share price and current state of affairs:
MDT Annual Shareholders Mtg - no mention of Titan, ENOS or development agreement. However, at approximately the 13 minute mark, a HUGO question was asked. The answer was: IDE submission to the FDA is anticipated sometime during the 1st calendar quarter of 2021, with CE at approximately the same time. Nothing more from MDT.
The content of the Titan/MDT development agreement(s) are still a mystery. I'm not aware of MDT developing a SP surgical robot, so I can only guess that our IP is being applied to HUGO. Anything available from anyone regarding the development would be welcome news on this board.
I offer this as food for thought. Someone's gobbling up shares as fast as those foolish enough to sell at these prices ($1.25-1.35). Logic tells me if it's a Wall St. type, they target big multiples. And my assumptions are just that, assumptions. Based on this level of interest, b/c TMDI's on the same path as was ISRG, but with what would appear on the surface to be a BIG partner. MDT has already declared their business model is to aggressively acquire tech. Which makes sense b/c they have a lot of cash, and only an MP robot at this time. Seems to be a very good fit sometime down the road.
I also looked at ColubrisMX. 2 RAS devices (SP and Endoluminal) and I question why didn't MDT work with them? Their videos are easy to find online to view their procedures. I can only conclude (without any evidence) MDT compared both, and ours was superior. Regardless of the fact that TMDI was "desperate" for cash, MDT would take the long-road and pick the best IP. Just my opinion. And these agreements take a long time to facilitate, and my guess is MDT had been talking with Titan much earlier in 2019.
I can't recall who on the board guessed that TMDI was worth about $10 a share, or about 1.2B? Please correct me if I'm remembering this incorrectly. My thoughts as a comparison are based on the time-value of money and the advantage of a leap forward to bring a SP product to market, as compared to starting from scratch. And the ability to defend the IP against any other competitor known at this time, I'd say the value is well north of $4B ($33-$34/share). That's just for the IP, b/c there will most likely not be any revenue from sales at the time of a BO. This is purely a guess, and I would ask anyone searching for better estimates to consider posts from FaceTrain, Flenderson, or offer a better source for further consideration by those on this board.
And finally, as of this past Thursday TMDI is no longer on the NASDAQ delisting list. We've traded over $1.00 for the past 10 days and are in compliance with membership guidelines. This was a bid distraction and a real pain-in-the-a$$ b/c shorters were using it for leverage. One less issue to deal with for at least another year. I don't disagree with the facts that Titan history has been near disastrous, but we have enough cash to work through next August, with what would appear to be a friendly partnership with the world's largest medical device company. I'm not a rainbows and blue-sky's investor, but feel very good about where we are in development, our working capital and abilities to raise more, and our vendor/development partnerships.
I offer this message b/c we're constantly searching for better information, and I know there are many new members reading this board. Every contribution is valuable, b/c we don't know what we don't know. Welcome. Good luck to all. Regards, BK.
AI
